The Sidoli lab is very grateful to current and past partners that have developed with us a special working relationship. We are always happy to support (and, obviously, be supported by) private companies that work in the same direction as us to improve science for the masses!

CelVivo

The Sidoli lab is the United States Center of Excellence of CelVivo IVS. CelVivo is a thriving company residing in the lovely Odense, Denmark. It produces a system to grow and maintain large 3D tissue mimetic structures. Functional spheroids is a major line of research of the Sidoli lab.

Immagina Biotechnology

Immagina is an Italian start-up situated close to the Alps (Trento, Italy). They are currently the only company innovating kits for high-resolution ribosome profiling. Their kits assist the easy purification and analysis of nascent RNA, proteome, and active ribosomes. Our lab is helping with the testing of their new proteomics approaches.

Veritomyx

Veritomyx is a company from the super-trendy Silicon Valley (Palo Alto, CA, USA). They develop computational solutions for mass spectrometry. The Sidoli lab is particularly excited by their innovative software named PeakInvestigator (link), which is able to resolve low-resolution spectra by computationally increasing 3-4x the resolution of the mass analyzer. By doing so, it is possible to reveal and precisely deconvolve overlapping (nearly isobaric) signals in mass spectra. We have been using PeakInvestigator to prove that complex proteomes can be identified with a simple ion trap (still unpublished).

Pearl River Laboratories

Pearl River Laboratories is a research organization located in a worldwide famous science hotspot: the New York Center for Innovation. With decades of expertise and experience in conjugated biologics, they develop processes and characterization and GMP analytics, enabling clinical trials and registration of biological products. Our lab has a contract with them to assist antibody characterization.

MEDIVAC

Medivac is a company situated in that special city named Parma (Italy), developing technology to collect Exhaled Breath Condensate (EBC). Collecting breath is probably the least invasive patient biopsy, and it is growing as a very promising approach to identify biomarkers for respiratory pathology and beyond. Medivac developed the “Turbo DECCS System”, which the Sidoli lab has acquired to develop new methods for rapid diagnostics.